Designed antiviral proteins inhibit SARS-CoV-2 in the lab

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. The findings are reported today, Sept. 9, in Science In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents. Coronaviruses…

Details

Small proteins against SARS-CoV-2 neutralize infection in cell culture

Using innovative computer-based approaches, researchers have developed protein inhibitors that block the interaction between the SARS-CoV-2 virus and human cell receptor ACE2. In cell culture, the most potent of these inhibitors could neutralize virus infection, paving the way for their use in therapies that could be delivered more easily than antibodies. SARS-CoV-2 infection generally begins…

Details

Special journal issue features Nemours heart specialists’ best practices for children

JACKSONVILLE, Fla. (September 9, 2020) – The September issue of Progress in Pediatric Cardiology will exclusively feature articles by pediatric cardiologists at Nemours Children’s Health System on echocardiography and other cardiac imaging techniques used in the care of children with cardiovascular disease. The 15 original papers and four case studies highlight best practices for imaging…

Details

ENT physicians and researchers showcase studies at Otolaryngology’s Virtual Annual Meeting

ALEXANDRIA, VA– During the AAO-HNSF 2020 Virtual Annual Meeting & OTO Experience, which runs from September 13 through October 25, the most current research in otolaryngology-head and neck surgery will be introduced during the Scientific Oral Presentations. Scientific Oral Presentations are a series of three- to six-minute presentations focusing on current evidence-based research, surgical procedures,…

Details